According to the study conducted by Kamerkar et al., electroporated MSC-derived exosomes containing an oncogenic Kras-targeting siRNA could suppress cancer in mouse pancreatic cancer models and remarkably improve overall survival [121]. Here, KRAS is linked to familial pancreatic carcinoma.